Actin recruitment to the Chlamydia inclusion is spatiotemporally regulated by a mechanism that requires host and bacterial factors.
The ability to exit host cells at the end of their developmental growth is a critical step for the intracellular bacterium Chlamydia. One exit strategy, extrusion, is mediated by host signaling pathways involved with actin polymerization. Here, we show that actin is recruited to the chlamydial inclusion as a late event, occurring after 20 hours post-infection (hpi) and only within a subpopulation of cells. This event increases significantly in prevalence and extent from 20 to 68 hpi, and actin coats strongly correlated with extrusions. In contrast to what has been reported for other intracellular pathogens, actin nucleation on Chlamydia inclusions did not 'flash', but rather exhibited moderate depolymerization dynamics. By using small molecule agents to selectively disrupt host signaling pathways involved with actin nucleation, modulate actin polymerization dynamics and also to disable the synthesis and secretion of chlamydial proteins, we further show that host and bacterial proteins are required for actin coat formation. Transient disruption of either host or bacterial signaling pathways resulted in rapid loss of coats in all infected cells and a reduction in extrusion formation. Inhibition of Chlamydia type III secretion also resulted in rapid loss of actin association on inclusions, thus implicating chlamydial effector proteins(s) as being central factors for engaging with host actin nucleating factors, such as formins. In conclusion, our data illuminate the host and bacterial driven process by which a dense actin matrix is dynamically nucleated and maintained on the Chlamydia inclusion. This late stage event is not ubiquitous for all infected cells in a population, and escalates in prevalence and extent throughout the developmental cycle of Chlamydia, culminating with their exit from the host cell by extrusion. The initiation of actin recruitment by Chlamydia appears to be novel, and may serve as an upstream determinant of the extrusion mechanism.
Division of Infectious Diseases, School of Public Health, University of California at Berkeley, CA, United States of America.
Elizabeth
E
Chin
Kelly
K
Kirker
Meghan
M
Zuck
Garth
G
James
Kevin
K
Hybiske
D000199:Actins / Q000235:genetics / Q000378:metabolism* / Q000648:ultrastructure; D000900:Anti-Bacterial Agents / Q000494:pharmacology; D001426:Bacterial Proteins / Q000378:metabolism; D002460:Cell Line; D002692:Chlamydia trachomatis / Q000378:metabolism* / Q000502:physiology; D002701:Chloramphenicol / Q000494:pharmacology; D003599:Cytoskeleton / Q000378:metabolism / Q000382:microbiology / Q000648:ultrastructure; D003600:Cytosol / Q000187:drug effects / Q000378:metabolism* / Q000382:microbiology; D049452:Green Fluorescent Proteins / Q000235:genetics / Q000378:metabolism; D006367:HeLa Cells; D054884:Host-Pathogen Interactions / Q000187:drug effects; D006801:Humans; D002479:Inclusion Bodies / Q000378:metabolism*; D008164:Luminescent Proteins / Q000235:genetics / Q000378:metabolism; D008855:Microscopy, Electron, Scanning; D008856:Microscopy, Fluorescence; D018715:Microscopy, Video; D019384:Nucleic Acid Synthesis Inhibitors / Q000494:pharmacology; D012293:Rifampin / Q000494:pharmacology; D059008:Time-Lapse Imaging
D000199:Actins; D000900:Anti-Bacterial Agents; D001426:Bacterial Proteins; D008164:Luminescent Proteins; D019384:Nucleic Acid Synthesis Inhibitors; C413663:fluorescent protein 583; D049452:Green Fluorescent Proteins; D002701:Chloramphenicol; D012293:Rifampin